EM1511J "Excess Mortality in Treated HIV Infection" (IM GR-112015)
This presentation discusses the maximum mortality benefit for people with HIV infection that can be achieved with modern combination antiretroviral therapy and the accuracy by which life expectancy estimates can be made. Finally it addresses implications of a recent worldwide change in treatment recommendations.
UT Southwestern faculty, fellows, residents and medical students, community physicians, nurse clinicians, physician assistants and nurses.
At the conclusion of this activity, the participant should be able to
- Describe current antiretroviral treatment recommendation for HIV infection.
- Describe changes in HIV-related mortality that have occurred over the last 20 years.
- Describe predictors for mortality for people on stable antiretroviral therapy.
Henning Drechsler, M.D.
Associate Professor of Internal Medicine
Division of Infectious Diseases
- 1.00 AMA